Literature DB >> 33264103

TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.

Shiyuan Liu1, Ying Tian2, Ying Zheng3, Yao Cheng1, Danjie Zhang1, Jiantao Jiang1, Shaomin Li1.   

Abstract

The Wnt/β-catenin pathway plays vital roles in diverse biological processes, including cell differentiation, proliferation, migration, and insulin sensitivity. A recent study reported that the DNA-binding transcriptional factor SIX3 is essential during embryonic development in vertebrates and capable of downregulating target genes of the Wnt/β-catenin pathway in lung cancer, indicating negative regulation of Wnt/β-catenin activation. However, regulation of the SIX3-Wnt/β-catenin pathway axis remains unknown. We measured the expression of TRIM27 and SIX3 as well as investigated whether there was a correlation between them in lung cancer tissue samples. Herein, we found that the E3 ubiquitin ligase, TRIM27, ubiquitinates, and degrades SIX3. TRIM27 induces non-small cell lung cancer (NSCLC) cell proliferation and metastasis, and the expression of β-catenin, S100P, TGFB3, and MMP-9 were significantly inhibited by SIX3. Furthermore, XAV939 is a selective β-catenin-mediated transcription inhibitor that inhibited TRIM27- and SIX3-mediated NSCLC cell proliferation, migration, and invasion. Clinically, lung tissue samples of cancer patients showed increased TRIM27 expression and decreased SIX3 expression. Taken together, these data demonstrate that TRIM27 acts as an oncogene regulating cell proliferation and metastasis in NSCLC through SIX3-β-catenin signaling.

Entities:  

Keywords:  SIX3; TRIM27; lung cancer; ubiquitination; β-catenin

Mesh:

Substances:

Year:  2020        PMID: 33264103      PMCID: PMC7803540          DOI: 10.18632/aging.104163

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  36 in total

1.  USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.

Authors:  Kuntian Luo; Yunhui Li; Yujiao Yin; Lei Li; Chenming Wu; Yuping Chen; Somaira Nowsheen; Qi Hu; Lizhi Zhang; Zhenkun Lou; Jian Yuan
Journal:  EMBO J       Date:  2017-03-31       Impact factor: 11.598

2.  Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27.

Authors:  Qingliang Zheng; Jin Hou; Ye Zhou; Yingyun Yang; Bing Xie; Xuetao Cao
Journal:  Cell Res       Date:  2015-09-11       Impact factor: 25.617

3.  Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.

Authors:  Baoxin Zhang; Chenfu Shen; Fengyun Ge; Tingting Ma; Zuping Zhang
Journal:  J Neurooncol       Date:  2017-06-22       Impact factor: 4.130

4.  Involvement of miR-140-3p in Wnt3a and TGFβ3 signaling pathways during osteoblast differentiation in MC3T3-E1 cells.

Authors:  Shigeko Fushimi; Tsutomu Nohno; Hitoshi Nagatsuka; Hironobu Katsuyama
Journal:  Genes Cells       Date:  2018-05-09       Impact factor: 1.891

5.  The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.

Authors:  Luyan Guo; Shuqin Chen; Hongye Jiang; Jiaming Huang; Wenyan Jin; Shuzhong Yao
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

6.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

Review 7.  Wnt signaling pathway in non-small cell lung cancer.

Authors:  David J Stewart
Journal:  J Natl Cancer Inst       Date:  2013-12-05       Impact factor: 13.506

Review 8.  The expression profile and clinic significance of the SIX family in non-small cell lung cancer.

Authors:  Qian Liu; Anping Li; Yijun Tian; Yu Liu; Tengfei Li; Cuntai Zhang; Jennifer D Wu; Xinwei Han; Kongming Wu
Journal:  J Hematol Oncol       Date:  2016-11-08       Impact factor: 17.388

9.  Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation.

Authors:  Xingjie Ma; Junjie Zhao; Fan Yang; Haitao Liu; Weibo Qi
Journal:  Oncotarget       Date:  2017-08-24

10.  FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin.

Authors:  Tao Liang; Xuxiao Ye; Yuanyuan Liu; Xinkai Qiu; Zuowei Li; Binqiang Tian; Dongliang Yan
Journal:  Exp Mol Med       Date:  2018-12-10       Impact factor: 8.718

View more
  6 in total

1.  Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer.

Authors:  Jia-Han Ding; Yi Xiao; Shen Zhao; Ying Xu; Yu-Ling Xiao; Zhi-Ming Shao; Yi-Zhou Jiang; Gen-Hong Di
Journal:  Mol Ther Oncolytics       Date:  2022-02-17       Impact factor: 7.200

Review 2.  The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.

Authors:  Xiaoxia Shi; Yixin Du; Shujing Li; Huijian Wu
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

3.  Knockdown of TRIM27 alleviated sepsis-induced inflammation, apoptosis, and oxidative stress via suppressing ubiquitination of PPARγ and reducing NOX4 expression.

Authors:  Meng Ning; Yingwu Liu; Donglian Wang; Jin Wei; Guoyong Hu; Pengcheng Xing
Journal:  Inflamm Res       Date:  2022-08-13       Impact factor: 6.986

Review 4.  Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.

Authors:  Nieves Lara-Ureña; Vahid Jafari; Mario García-Domínguez
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

Review 5.  The roles and targeting options of TRIM family proteins in tumor.

Authors:  Yuxin Zhang; Wenzhou Zhang; Lufeng Zheng; Qianqian Guo
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988

Review 6.  Emerging roles of TRIM27 in cancer and other human diseases.

Authors:  Chengpeng Yu; Dean Rao; Tiantian Wang; Jia Song; Lei Zhang; Wenjie Huang
Journal:  Front Cell Dev Biol       Date:  2022-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.